Healthcare Services Group to acquire NEXDINE Hospitality for $93.5 million

Healthcare Services Group Inc. (HCSG) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 07, 2026. On October 6, 2026, Healthcare Services Group, Inc. (the "Company") entered into a Membership Interest Purchase Agreement (the "Purchase Agreement") with Real Artisan Brands, LLC and certain other parties thereto (collectively, the "Seller Parties"), pursuant to which the Company agreed to acquire all of the outstanding equity interests of NexDine, LLC and Xendella, LLC (collectively, "NEXDINE Hospitality") (the "Acquisition"). Pursuant to the Purchase Agreement, the aggregate purchase price for the Acquisition is approximately $93.5 million, subject to customary adjustments, plus contingent consideration payable upon the achievement of certain performance conditions following the closing. The Company funded the cash consideration payable at closing using cash on hand. The Purchase Agreement contains customary representations, warranties, covenants and termination provisions. The foregoing description of the Purchase Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference. The full text of this SEC filing can be retrieved at: Any exhibits and associated documents for this SEC filing can be retrieved at: Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares. (END) Dow Jones Newswires October 07, 2026 17:00 ET (21:00 GMT) Copyright (c) 2026 Dow Jones & Company, Inc. The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.